Gastroenterology Unit, Valduce Hospital
Como, 22100, Italy
NCT Number: NCT05492656
The endoscopist performances in the optical diagnosis (OD) of colonic polyps with the available technologies vary widely across centers and across endoscopists. The OD process is strictly related to the operator training and expertise. Most of the available studies in optical characterization have been carried out by expert endoscopist in tertiary high volume centers, and weren't replied on large unselected populations. For these reasons, at the moment the optical characterization of polypoid lesions can't replace, in the everyday clinical practice, the histopathological evaluation of resected polyps. Artificial intelligence (AI)-based systems have the potential to make optical characterization process of colonic polyps easier and more reliable, thus supporting the endoscopist in the application of leave-in-situ and of resect-and-discard strategies. The implementation of such strategies would lead to a significant economic saving and a decrease of risks and complications related to unnecessary polypectomy. GI-Genius System (Medtronic Inc, Minneaopolis, USA) is a CNN-based algorithm allowing an automatic OD of colonic polyps. This system does not require dedicated light setting for polyp evaluation as it works with white light high definition images, which are the actual standard in every endoscopic unit. During colonoscopy, when a polyp is framed within the screen, a green detection box surrounds the polyp and the system automatically provides (whenever possible) the optical diagnosis labeling the polyp as "adenoma or non-adenoma". When the automatic polyp charaterization is unfeasible the label "no prediction" appears. Nowadays only few data about the feasibility and performances of this system in clinical practice are available. In addition published studies are mostly focused on technical rather thann clinical issues. The present prospective observational trial is primarily aimed at evaluating the diagnostic accuracy of optical characterization of colonic polyps <= 1 cm using GI-Genius System in daily clinical practice, having histopathology examination as reference standard.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Como, 22100, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Consecutive outpatients undergoing colonoscopy for one of the following indication:
Exclusion criteria
Time frame: Entire study duration (3 months)
Numer of correctly characterized polyps using AI/total number of detected polyps
Time frame: Entire study duration (3 months)
Number of characterizable polyps using AI/total number of detected polyps
Time frame: Entire study duration (3 months)
CADx sensitivity (rate of TP/TP+FN) will be calculated having histopathology as reference standard and according to polyp size and location
Time frame: Entire study duration (3 months)
CADx specificity (rate of TN/TN+FP) will be calculated having histopathology as reference standard according to polyp size and location
Time frame: Entire study duration (3 months)
CADx positive predictive value (rate of TP/TP+FP) will be calculated having histopathology as reference standard according to polyp size and location
Time frame: Entire study duration (3 months)
CADX negative predictive value (rate of TN/TN+FN) will be calculated having histopathology as reference standard according to polyp size and location
Valduce Hospital
Other
Accuracy and Feasibility of CADx System for White Light Colonic Polyp Characterization
Acronym: GIC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04673136
Adenoma Colon, Colonic Diseases
Alicante, Spain
View Trial DetailsNCT05869838
Colonic Polyp, Colonic Polyps
Hanover, Germany
View Trial DetailsNCT04858477
Colonic Polyp, Colonic Polyps
Brooklyn, New York, United States
View Trial DetailsNCT05322993
Colonic Polyp, Colonic Polyps
Bergen, Vestland, Norway
View Trial Details